Australia’s AMP Capital has doubled down on its Asia Pacific infrastructure debt strategy with the creation of a dedicated team based across Sydney and Singapore.
It follows a $6.2 billion final close last year for AMP’s fourth infrastructure debt fund and a $2.5 billion close in 2017 for its third. The first two funds in the strategy raised $503 million and $1.1...
Insilico Medicine, which leverages artificial intelligence (AI) technology to speed up the drug development process, has closed a $255 million Series C funding round led by Warburg Pincus.
A consortium led by DCP Capital Partners has finalized terms for a $5.7 billion privatization of US-listed Chinese online recruitment platform 51job.
PE-backed Abbisko Therapeutics, which focuses on the discovery and development of innovative and differentiated small molecule oncology therapies, has filed for a Hong Kong IPO.